Search the Newsreel

ETFs Investing in AngioDynamics, Inc. Stocks

This article lists various Exchange Traded Funds (ETFs) that hold AngioDynamics, Inc. (A0B9A5) stocks, providing investors with diversification opportunities. The ETFs include a range of styles such as passive and active, and focus on small-cap, micro-cap, health care, and total market segments. Key financial …

Allspring Global Investments Holdings LLC Grows Stake in Diodes Incorporated $DIOD

Allspring Global Investments Holdings LLC increased its stake in Diodes Incorporated by 8% in the first quarter, bringing its total holdings to 254,167 shares valued at $17.5 million. This increase comes despite notable insider selling from CEO Gary Yu and SVP Andy Tsong. Diodes …

Form 4 AngioDynamics Inc For: 21 July By Investing.com

This article reports on a Form 4 filing for AngioDynamics Inc (ANGO) on July 21st, published on July 22, 2026. The article itself is very brief, mainly serving as a notification of the filing and providing a current stock performance for ANGO. It appears …

AngioDynamics (ANGO) SVP uses 8,228 shares to cover RSU tax obligations

Laura Piccinini, SVP International at AngioDynamics (ANGO), disposed of a total of 8,228 shares of common stock across three transactions on July 16, 17, and 20, 2026. These dispositions were exempt and made to satisfy tax withholding obligations related to the vesting of restricted …

Tax-withholding of 45,711 shares by AngioDynamics (ANGO) CEO disclosed

AngioDynamics (ANGO) CEO James C. Clemmer reported five exempt dispositions of common stock totaling 45,711 shares between July 16-20, 2026. These transactions were for tax withholding obligations related to the vesting of previously granted Restricted Stock Units (RSUs), with per-share prices ranging from $13.51 …

AngioDynamics (ANGO) SVP reports 3,838-share tax withholding event

AngioDynamics Inc. SVP/GM Vascular Access, Chad Thomas Campbell, reported tax-related dispositions of 3,838 shares of common stock. These shares were withheld over three separate dates (July 16, 17, and 20, 2026) to cover tax withholding obligations arising from the vesting of restricted stock units …

AngioDynamics (ANGO) Q4 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Tuesday, July 14, 2026 at 8:00 a.m. ET CALL PARTICIPANTS President and Chief Executive Officer - Jim ClemmerExecutive Vice President and Chief Financial Officer - Steve Trowbridge TAKEAWAYS Total Net Sales -- $86.6 million in the fourth quarter, …

Summit Global Investments Raises Position in Diodes Incorporated $DIOD

Summit Global Investments increased its stake in Diodes Incorporated (NASDAQ:DIOD) by 365.9% in Q1, now holding 19,927 shares valued at $1.36 million. The semiconductor company has a "Moderate Buy" consensus rating from analysts with an average price target of $113.00, and recently reported better-than-expected …

ANGO Q2 2026 Earnings: Narrower Loss Surprises, but Stock Slides 4.46% - Operating Income Trends

Biodesix, Inc. (NASDAQ:BDSX) Given Consensus Recommendation of "Moderate Buy" by Analysts

Analysts have assigned Biodesix, Inc. (NASDAQ:BDSX) a consensus rating of "Moderate Buy," with an average 12-month price target of $28.33. This rating comes from five analysts, with three recommending a buy, one a strong buy, and one a sell. The company's recent earnings report …

AngioDynamics (NASDAQ:ANGO) Rating Lowered to "Strong Sell" at Zacks Research

Diodes Acquires ElevATE Semiconductor in $250 Million Deal to Expand ATE Market

Diodes Incorporated has announced a definitive agreement to acquire ElevATE Semiconductor for $250 million in an all-cash transaction. This acquisition will expand Diodes' market penetration in the Automated Test Equipment (ATE) industry, leveraging ElevATE's specialized IC development. The deal is expected to be immediately …

AngioDynamics | SCHEDULE 13G/A: Others

This article is a SCHEDULE 13G/A filing for AngioDynamics, indicating an "Others" category. As a regulatory document, it provides required disclosure of beneficial ownership. The provided content indicates "Document", suggesting the full filing is linked or accessible elsewhere.

H.C. Wainwright raises AngioDynamics stock price target on growth

H.C. Wainwright has increased its price target for AngioDynamics (NASDAQ:ANGO) shares to $19 from $16, maintaining a Buy rating, following the company's strong fiscal fourth-quarter and full-year 2026 results. The medical technology firm reported significant growth in net sales, particularly in its Med Tech …

Calamos Advisors LLC Invests $1.80 Million in Diodes Incorporated $DIOD

Calamos Advisors LLC has made a significant investment in Diodes Incorporated, acquiring 26,343 shares valued at approximately $1.80 million during the first quarter. Wall Street analysts have a "Moderate Buy" rating for DIOD, with a consensus target price of $113. The company recently reported …

Diodes Inc (DIOD) holder Dimensional discloses 4.8% ownership stake

Dimensional Fund Advisors LP has reported a 4.8% beneficial ownership stake in Diodes Inc (DIOD), totaling 2,200,506 common shares. The firm holds sole voting power over 2,155,433 shares and sole dispositive power over all 2,200,506 shares. This filing, a SCHEDULE 13G/A, indicates that the …

Full Transcript: AngioDynamics Q4 2026 Earnings Call

AngioDynamics reported strong Q4 fiscal year 2026 results with an 8% revenue increase to $86.6 million, driven by 16.7% growth in its MedTech segment, which now accounts for 47% of total revenue. The company highlighted 20 consecutive quarters of double-digit growth for its Aureon …

AngioDynamics (ANGO) Stock Faces Profitability Question As Q4 EPS Loss Deepens Bearish Narrative

AngioDynamics (ANGO) concluded FY 2026 with a Q4 basic EPS loss of US$0.27 and a full-year basic EPS loss of US$0.88 on US$320.2 million in revenue, continuing a trend of net losses. While forecasts project 72.2% annual earnings growth and profitability within three years, …

Diodes Incorporated to Announce Second Quarter 2026 Financial Results on August 5, 2026

Diodes Incorporated (Nasdaq: DIOD) will host a conference call on August 5, 2026, at 4:00 p.m. Central Time to discuss its second quarter 2026 financial results. The company plans to release the results at 3:05 p.m. Central Time on the same day. Investors and …

Diodes Incorporated (Nasdaq: DIOD) schedules Q2 2026 earnings call and webcast

Diodes Incorporated (Nasdaq: DIOD) is scheduled to hold its Q2 2026 earnings conference call and webcast on Wednesday, August 5, 2026, at 4:00 p.m. Central Time. The company plans to release its financial results an hour earlier on the same day. The call will …

Diodes to announce Q2 2026 results, schedules Aug. 5 call and webcast

Diodes (DIOD) will report its second-quarter 2026 financial results and host a conference call on August 5, 2026. The Q2 results will be announced at 3:05 p.m. CT (4:05 p.m. ET), followed by a conference call at 4:00 p.m. CT (5:00 p.m. ET) with …

Freedom Broker raises AngioDynamics stock price target to $17 on margin outlook

Freedom Broker increased its price target for AngioDynamics (NASDAQ: ANGO) to $17.00 from $16.00, reiterating a Buy rating due to an improved margin outlook. This revision follows an upward adjustment of fiscal 2027 adjusted EBITDA estimates by 29% and expectations of growing margins from …

AngioDynamics Q4 Earnings Beat Estimates, Gross Margin Expands

AngioDynamics (ANGO) reported an adjusted loss per share of 7 cents for Q4 fiscal 2026, which was narrower than analysts' expectations, and full-year fiscal 2026 adjusted loss also beat estimates. The company's Q4 revenues rose 8% year-over-year to $86.6 million, exceeding the Zacks Consensus …

Plano-Based Diodes to Acquire San Diego’s ElevATE Semiconductor for $250M

Diodes Incorporated, based in Plano, is set to acquire San Diego's ElevATE Semiconductor for $250 million in an all-cash deal. This acquisition will expand Diodes' presence in the automated test equipment chip market, with ElevATE specializing in integrated circuits for this growing industry. Diodes …

Press Release: Diodes Incorporated to Acquire ElevATE Semiconductor, Expanding Analog and Mixed-Signal Portfolio

Diodes Incorporated announced its intent to acquire ElevATE Semiconductor, a leader in high-performance mixed-signal products for the industrial and automotive markets, particularly in analog and mixed-signal System-on-Chips (SoCs). This strategic acquisition aims to expand Diodes' addressable market, enhance its analog product portfolio, and leverage …

AngioDynamics (ANGO) Reports Q4 Loss, Beats Revenue Estimates

AngioDynamics (ANGO) reported a Q4 loss of $0.07 per share, outperforming the Zacks Consensus Estimate of a $0.11 loss, and exceeded revenue expectations with $86.61 million against an $80.16 million estimate. This marks the fourth consecutive quarter the company has surpassed both EPS and …

Biodesix Inc. (BDSX) Gains Momentum: Key Levels to Watch After 3% Rally - Common Gap

Oxford BioDynamics expands diagnostic platform as Orion launch accelerates despite funding pressures (OBD)

BDSX Forecast — Price Target — Prediction for 2027

When Will IODM Limited (ASX:IOD) Breakeven?

Canaccord Lifts PT on Biodesix (BDSX) on Raised Revenue Assumptions

Biodesix stock price target raised to $22 by Canaccord on revenue growth

Biodesix, Inc. (BDSX) Reports Q1 Loss, Tops Revenue Estimates

How The Biodesix (BDSX) Investment Story Is Shifting After Guidance And New US$30 Target

Biodesix, Inc. Reports Estimated Q4 2025 Revenue of $28.8 Million, Achieving 41% Growth and Full-Year Revenue of $88.5 Million, Up 24%

AIM Market Roundup: WH Ireland, Bradda Head, Oxford Biodynamics